Lizofosfatidilserin

Lizofosfatidilserin je lizofosfolipid koji inicira TLR 2.

Nedavna studija je pokazala da on ne stimuliše normalne leukocite.^[1] On pojačava transport glukoze, čime se snižavaju nivoi glukoze, dok sekrecija insulina ostaje nepromenjena.^[2]

Reference[уреди | уреди извор]

^ Park KS, Lee HY, Kim MK, Shin EH, Bae YS (2005). „Lysophosphatidylserine stimulates leukemic cells but not normal leukocytes”. Biochem. Biophys. Res. Commun. 333 (2): 353—8. PMID 15946646. doi:10.1016/j.bbrc.2005.05.109.
^ Yea, Kyungmoo; Jaeyoon Kima; et al. (2009). „Lysophosphatidylserine regulates blood glucose by enhancing glucose transport in myotubes and adipocytes”. Biochemical and Biophysical Research Communications. 378 (4): 783—788. PMID 19063864. doi:10.1016/j.bbrc.2008.11.122.

Spoljašnje veze[уреди | уреди извор]

Lysophosphatidylserine на US National Library of Medicine Medical Subject Headings (MeSH)

[pmid15946646-1] Park KS, Lee HY, Kim MK, Shin EH, Bae YS (2005). „Lysophosphatidylserine stimulates leukemic cells but not normal leukocytes”. Biochem. Biophys. Res. Commun. 333 (2): 353—8. PMID 15946646. doi:10.1016/j.bbrc.2005.05.109.

[2] Yea, Kyungmoo; Jaeyoon Kima; et al. (2009). „Lysophosphatidylserine regulates blood glucose by enhancing glucose transport in myotubes and adipocytes”. Biochemical and Biophysical Research Communications. 378 (4): 783—788. PMID 19063864. doi:10.1016/j.bbrc.2008.11.122.

[1]

[2]